Health care industry
Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks
Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Oracle : The tech giant had a mixed quarter. But it announced new artificial intelligence partnerships with Alphabet ‘s Google and Microsoft -backed OpenAI. Oracle also reported strong RPO, short for remaining performance obligation. RPO is what contracted […]
Read More
Weight loss boom is spurring sales of protein, meal replacement products, Vitamin Shoppe CEO says
The weight loss boom is pushing consumers to spend more on protein supplement products. That’s according to new data from The Vitamin Shoppe’s 2024 Health & Wellness Trend Report, an annual study of 2,000 Americans that provides insight into top consumer trends in the nutritional supplements industry. As more Americans take weight loss treatments like […]
Read More
FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approval
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty […]
Read More
Roche alleges counterfeit diabetes medical devices were sold on Amazon
Roche Diabetes Care Inc. Accu-Chek brand glucose test strips are arranged for a photograph in the Brooklyn borough of New York, U.S., on Thursday, April 4, 2019. Alex Flynn | Bloomberg | Getty Images Roche, one of the world’s largest biotech companies, said “dangerous counterfeits” of its diabetes medical devices ended up for sale on […]
Read More
Fda approves two new Abbott above-the-counter steady glucose monitors
Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories announced on Monday it obtained acceptance from the U.S. Food items and Drug Administration for two new constant […]
Read More
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Empty bottles of Moderna’s Covid-19 vaccine. Fred Tanneau | AFP | Getty Images Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. The biotech company is the first to release positive phase three data on a […]
Read More
DOJ settles CityMD Covid fraud allegations for $12 million
Persons wait in in a queue to enter CityMD, a health and fitness clinic that features coronavirus illness (COVID-19) tests, on the Higher West Aspect as the Omicron coronavirus variant continues to spread in Manhattan, New York Town, U.S., December 19, 2021. Andrew Kelly | Reuters Walgreens-backed CityMD will fork out $12.04 million to settle […]
Read More
Trump claims credit for Biden’s insulin price cap
President Joe Biden and former President Donald Trump 2024. Kevin Lamarque | Jay Paul | Reuters Former President Donald Trump on Saturday recognized that the price of insulin is lower under President Joe Biden, but he still wants voters to credit his own administration. “Low INSULIN PRICING was gotten for millions of Americans by me, and […]
Read More
The Covid-19 pandemic worsened a child care crisis, and it’s costing U.S. businesses billions
Vadym Buinov | Moment | Getty Images The Covid-19 pandemic brought to the surface both cracks and resilience in the American economy, with child care taking center stage as day cares shuttered, schools went remote and parents attempted to juggle their children with their jobs. While employment in the child care sector has made a […]
Read More
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus vaccine to adults ages 50 to 59 who are at increased risk of getting severely sick from the potentially lethal virus. The shot, called Arexvy, […]
Read More